Literature DB >> 28920079

Parkin New Cargos: a New ROS Independent Role for Parkin in Regulating Cell Division.

David C Stieg1, Katrina F Cooper1.   

Abstract

Cell cycle progression requires the destruction of key cell cycle regulators by the multi-subunit E3 ligase called the anaphase promoting complex (APC/C). As the cell progresses through the cell cycle, the APC/C is sequentially activated by two highly conserved co-activators called Cdc20 and Cdh1. Importantly, APC/CCdc20 is required to degrade substrates in G2/M whereas APCCdh1 drives the cells into G1. Recently, Parkin, a monomeric E3 ligase that is required for ubiquitin-mediated mitophagy following mitochondrial stress, was shown to both bind and be activated by Cdc20 or Cdh1 during the cell cycle. This mitotic role for Parkin does not require an activating phosphorylation by its usual kinase partner PINK. Rather, mitotic Parkin activity requires phosphorylation on a different serine by the polo-like kinase Plk1. Interestingly, although ParkinCdc20 and ParkinCdh1 activity is independent of the APC/C, it mediates degradation of an overlapping subset of substrates. However, unlike the APC/C, Parkin is not necessary for cell cycle progression. Despite this, loss of Parkin activity accelerates genome instability and tumor growth in xenograft models. These findings provide a mechanism behind the previously described, but poorly understood, tumor suppressor role for Parkin. Taken together, studies suggest that the APC/C and Parkin have similar and unique roles to play in cell division, possibly being dependent upon the different subcellular address of these two ligases.

Entities:  

Keywords:  Anaphase promoting complex; Cell cycle; Parkin; Parkinson’s disease; Reactive oxygen species; Tumor suppressor

Year:  2016        PMID: 28920079      PMCID: PMC5597248          DOI: 10.20455/ros.2016.857

Source DB:  PubMed          Journal:  React Oxyg Species (Apex)


  75 in total

1.  Parkin: a multipurpose neuroprotective agent?

Authors:  Mel B Feany; Leo J Pallanck
Journal:  Neuron       Date:  2003-04-10       Impact factor: 17.173

Review 2.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

3.  SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.

Authors:  Hyun-Seok Kim; Athanassios Vassilopoulos; Rui-Hong Wang; Tyler Lahusen; Zhen Xiao; Xiaoling Xu; Cuiling Li; Timothy D Veenstra; Bing Li; Hongtao Yu; Junfang Ji; Xin Wei Wang; Seong-Hoon Park; Yong I Cha; David Gius; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

4.  Ubiquitin is phosphorylated by PINK1 to activate parkin.

Authors:  Fumika Koyano; Kei Okatsu; Hidetaka Kosako; Yasushi Tamura; Etsu Go; Mayumi Kimura; Yoko Kimura; Hikaru Tsuchiya; Hidehito Yoshihara; Takatsugu Hirokawa; Toshiya Endo; Edward A Fon; Jean-François Trempe; Yasushi Saeki; Keiji Tanaka; Noriyuki Matsuda
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

5.  USP8 and PARK2/parkin-mediated mitophagy.

Authors:  Thomas M Durcan; Edward A Fon
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

6.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

7.  Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.

Authors:  Maria Cristina Picchio; Eric Santos Martin; Rossano Cesari; George Adrian Calin; Sai Yendamuri; Tamotsu Kuroki; Francesca Pentimalli; Manuela Sarti; Kristine Yoder; Larry R Kaiser; Richard Fishel; Carlo Maria Croce
Journal:  Clin Cancer Res       Date:  2004-04-15       Impact factor: 12.531

8.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.

Authors:  Sven Geisler; Kira M Holmström; Diana Skujat; Fabienne C Fiesel; Oliver C Rothfuss; Philipp J Kahle; Wolfdieter Springer
Journal:  Nat Cell Biol       Date:  2010-01-24       Impact factor: 28.824

9.  Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1.

Authors:  Zhizhong Dong; Boris Ferger; Jean-Charles Paterna; Denise Vogel; Sven Furler; Maribel Osinde; Joram Feldon; Hansruedi Büeler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

10.  The PINK1/Parkin pathway regulates mitochondrial morphology.

Authors:  Angela C Poole; Ruth E Thomas; Laurie A Andrews; Heidi M McBride; Alexander J Whitworth; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.